DEA cut from Prop 65
This article was originally published in The Rose Sheet
Executive Summary
Diethanolamine will not be listed under Prop 65, California's Office of Environmental Health Hazard Assessment announces March 7. Based upon public comments, OEHHA concludes "it is not clear that the scientific criteria for listing under the authoritative bodies have been met." Office determined sufficient criteria to propose listing the ingredient in 1999 despite attempts by the Cosmetic, Toiletry & Fragrance Association to oppose the listing. Decision coincides with recent recommendation by National Toxicology Program Board of Scientific Counselors subcommittee not to include DEA in NTP's upcoming 11th Report on Carcinogens (1"The Rose Sheet" Nov. 25, 2002, p. 5)...
You may also be interested in...
DEA Exclusion From 11th Report On Carcinogens Advised By NTP Panel
Existing data suggesting diethanolamine may pose a safety risk do not meet National Toxicology Program criteria to be designated a possible human carcinogen, an NTP Board of Scientific Counselors subcommittee concluded at a meeting in Bethesda, Md. Nov. 19
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.